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Abstract
Background: Hope or hopefulness enhances coping and improves quality of life in persons with chronic or
incurable illnesses. Lack of hope is associated with depression and anxiety, which impact negatively on quality of
life. In Tanzania, where HIV prevalence is high, the rates of depression and anxiety are over four times higher
among people living with HIV (PLH) compared to persons not infected and contribute annual mortality among
PLH. Tanzania has a shortage of human resources for mental health, limiting access to mental health care.
Evidence-based psychosocial interventions can complement existing services and improve access to quality mental
health services in the midst of human resource shortages. Facilitating hope can be a critical element of non-
pharmacological interventions which are underutilized, partly due to limited awareness and lack of hope measures,
adapted to accommodate cultural context and perspectives of PLH. To address this gap, we developed and
validated a local hope measure among PLH in Tanzania.
Methods: Two-phased mixed methods exploratory sequential study among PLH. Phase I was Hope-related items
identification using deductive, inductive approaches and piloting. Phase II was an evaluation of psychometric
properties at baseline and 24 months. Classical test theory, exploratory, confirmatory factor analysis (CFA) were used.
Results: Among 722 PLH, 59% were women, mean age was 39.3 years, and majority had primary school level of education.
A total of 40 hope items were reduced to 10 in a three-factor solution, explaining 69% of variance at baseline, and 93% at
follow-up. Internal consistency Cronbach's alpha was 0.869 at baseline and 0.958 at follow-up. The three-factor solution
depicted: positive affect; cognition of effectiveness of HIV care; and goals/plans/ future optimism. Test-retest reliability was
good (r = 0.797) and a number of indices were positive for CFA model fit, including Comparative Fit Index of 0.984.
Conclusion: The developed local hope scale had good internal reliability, validity, and its dimensionality was confirmed
against expectations. The fewer items for hope assessment argue well for its use in busy clinical settings to improve HIV care
in Tanzania. Hope in this setting could be more than cognitive goal thinking, pathway and motivation warranting more
research.
Trial registration: The intervention was registered in USA ClinicalTrials.gov on September 26, 2012, Registration number:
NCT01693458.
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Background
Hope has multiple definitions including a feeling of ex-
pectation and desire for a particular thing to happen char-
acterized by having a goal/desire, agency (inner force to
act) and plans on how to achieve the goals [1, 2]. Other
definitions include a perceived ability to produce pathways
to achieve desired goals and to motivate oneself to use
those pathways [3]; a positive psychosocial strength [1].
Hope is more than optimism [4]; psychologists have in
recent years differentiated hope and optimism, by empha-
sizing hope as a positive future expectation in which one
must have a role to play in order to establish it. Optimism
is having a positive future expectation without necessarily
playing any role to establish it [5].
Hope is also shaped by culture and social structural issues
of the population where an individual exists. Culture values
including religious faith, family unit, and honor can act as a
source of resilience, driving social aspirations, motivations,
self-respect and dignity [6–9]. However social structure
inequalities can impede realization of dreams and one’s
cultural expectation thus a source of stress frustration and
hopelessness. These include poverty, social injustice,
war crises and displacements, ineffective governance
etc. [7–10]. Other researchers also add that social hope
comes from an individual ability to perceive the existing
social mobility (possibilities that life can offer) and its
opposite or hopelessness is a sense of entrapment or a
sense of having nowhere to go and not poverty [11].
The struggle to maintain culturally acceptable stan-
dards in the midst of structural limitations can be a
source of distress and lack of hope. Cultural norms and
values have thus been described as “a double aged
sword” which can bring social functioning or social vio-
lence and thus distress [12].
Interventions that aim to increase hope have been
reported across the globe to help patients cope with
difficult situations such as living with chronic or incurable
disease, cope with the process of aging, adherence to pro-
longed care procedures and daily medications [13–16] as
well as reducing depressive, anxiety symptoms and in-
creasing healthier lifestyles [17]. Hope has a negative
association with depression, anxiety, mixed depression
and anxiety and less specific psychological distress [18, 19]
and is frequently applied for managing hopelessness and
preventing mild to moderate mood disorders [20–23].
Hope is also a mediator of resilience, well-being [24], and
in general population health being hopeful contributes to
reductions in all-cause mortality [25]. With positive future
optimism, support, and a perceived role to play, hope is a
core dimension of recovery from mental illness and sub-
stance abuse [26, 27]. Among PLH, hope increases coping
[28, 29], adherence to HIV care and medications [30] thus
potentially improving ART treatment outcomes. Hope-
lessness, on the other hand, is associated with increased
risk of anxiety or depressive disorders [31–35], predicts an
increase in depression-anxiety co-morbidity [36] and sui-
cidal behaviors [37, 38]. Increased hopelessness is a con-
tributing factor to increased engagement in HIV-related
risk behaviors [39, 40]. Focused interventions that impact
positively on hope would thus add an important compo-
nent to HIV prevention, care and treatment services.
Although studies indicate integrating care for some of
the common mental health disorders including depres-
sion, alcohol use disorders and anxiety could improve
antiretroviral (ART) treatment outcomes [41] among
PLH, there is still limited access to quality mental health
services within HIV care and treatment services [42, 43].
While in part, this could be a consequence of an existing
crisis of human resource for health with lack of sufficient
trained mental health care professionals, it is important
that they are recognized and managed by general health
care providers with an option to refer severe cases [44].
Increasing hope is a non-pharmacological approach that
could alleviate hopelessness and mood disorders of mild
to moderate forms. However, there is limited use and inte-
gration of hope concepts and related non-pharmacological
therapies in Tanzania and other African countries. This is
in part due to the lack of relevant measures of hope
developed for use in African populations living in
SSA [28, 45, 46]. Almost all the tools for measuring
hope were adopted from western cultural settings and
most of them have not been validated in African set-
tings. An Unpublished pilot study conducted shortly
before this study that utilized the commonly used
hope measure of Snyder hope scale, to measure hope
among PLH in Dar es Salaam Tanzania revealed Cron-
bach’s alpha internal consistence of 60 which is way below
the recommended cut offs of 70 and above [47]. Another
study conducted in Tanzania that utilized the same scale to
measure hope among women in microfinancing groups, re-
ported that the women scored very high and many reached
very near to the maximum attainable scores [48]. The same
study also showed that the Snyder scale had poor discrim-
ination and strong evidence of acquiescence response bias.
This indicates the need to further explore potential hope
scales developed in African cultural settings.
In order to address these gap, we developed and vali-
dated a measure of hope that is based in high HIV
prevalence setting of urban Africa.
Study objective
The aim of this study was to develop and validate a local
measure for hope among PLH in a high HIV prevalence
and low-income setting that will reflect understandings of
hope among PLH and consider the relevant terms used to
express hope in this socio-cultural context [49]. This was
an adjunct study done to complement the main larger
NAMWEZA study.
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Methods
Study setting
The study was conducted in Dar es Salaam, the largest
city in Tanzania, with a population of 4.5 million, and
just over half (51%) residing in informal settlements
[50]. The city has the third highest prevalence of HIV in
the country of 6.2% against a national prevalence of 5.2%
[45]. Annual mortality among PLH accessing antiretro-
viral (ART) medication is 13.1% [51], and depressive dis-
orders are among mortality contributing factors [51–54].
Rates of clinically significant depressive symptoms in
PLH range from 36 to 56%. PLH with moderate to se-
vere depression during ART initiation have a mortality
rate that is nearly twice as high compared to those who
are not depressed [41]. Phase I was done in 8 large HIV
care and Treatment Clinics (CTCs). The CTCs are out-
patient clinics available in all government health care
facilities which offer health care services exclusively for
PLH. The clinics run from Monday to Friday for adults
while Saturdays are for pediatric and adolescents. Phase
I was conducted 8 large CTCs from the 3 districts of
Dar es Salaam. The large CTCs were defined as CTCs
that had accumulated enrolled over 5000 PLH before
the study began. The CTCs from each district were se-
lected proportionately meaning the district with more
CTCs contributed more CTCs to participate in this
study. Four CTCs we selected from Ilala district, 2
from Temeke and 2 from Kinondoni district. Phase II
was done at one large CTC in the largest district of
Kinondoni, Dar es Salaam, which was by the time the
study was starting the highly populated district in Dar
es Salaam over 50% of the city inhabitants.
Study design
We conducted a two-phase mixed method exploratory
sequential study in three phases [55] with 722 PLH.
Phase I included 10 focus group discussions (FGDs) and
8 in-depth interviews with a total of 78 PLH, pile sorting
and expert rating which identified hope domains and po-
tential questions which were subsequently piloted them
among 318 PLH.
Phase II was a validation phase where the local hope
items from the pilot were further tested through a longi-
tudinal sample of 326 PLH who were participants of the
larger psychosocial support structured group interven-
tion called NAMWEZA [56], using baseline and 24
months follow-up data.
Description of NAMWEZA intervention
NAMWEZA
The term comprises truncated Kiswahili words (NAAM
TUNAWEZA meaning Yes, together we can!). Is the
brand name of a strength-based intervention that utilizes
Appreciative Inquiry strategies to motivate participants
towards being more positive in building better relation-
ships and in developing and implement individual future
life plans. Although this approach is more commonly
used in business and other settings with focus on foster-
ing organizational change, it has been used recently
within family and community initiatives as well as health
interventions [57, 58]. As used in NAMWEZA, the Ap-
preciative Inquiry Approach involved searching for the
best in people, and the world around them through a
systematic discovery of individual strengths, what is go-
ing well in ‘life’ and existing support systems instead of
searching for what is not working [59]. The Appreciative
Inquiry Approach is linked with a positive psychology
theoretical framework since it relates to exploring the
development of hope and future-mindedness and focus-
ing on self-efficacy and an affirmative perspective of the
future [60]. The initial curriculum of NAMWEZA was
created as a structured, manualized, and in a closed
psychosocial group’s format for delivery by trained peers.
It emphasised on increasing awareness of one’s own and
others inherent abilities and existing social supports; and
facilitating effective communication, problem solving,
goal setting, and future planning skills. Participants
learnt to dream about positive futures, and question in
depth the steps needed to attain this future that in-
formed goal setting and action planning. In addition,
NAMWEZA was implemented within a Stepping Stones
Intervention framework including components of experi-
ential learning, real life practice of skills and feed-back
as well as understanding and challenging cultural bar-
riers to change [61–63]. These additions aimed to allow
the NAMWEZA strength-based approach to have higher
contextual relevance for piloting as an evidence-based
structured psychosocial support intervention delivered
in group format, for HIV prevention in PLH, with focus
on facilitating hope, reducing risk behaviours and ad-
dressing other structural drivers of HIV transmission.
Characteristics of study participants
The study population included adults living with
HIV/AIDS;
Eligibility criteria
Phase I (Focus group discussions (FGDs), In-depth inter-
views (IDIs) and a pilot survey): This phase included
adult; 18 years of age and above, living with HIV/AIDS,
and enrolled for care the selected CTCs, on antiretro-
viral (ART) medications for at least 6 months, and agrees
to participate and provides a signed informed consent.
In addition to phase I participants of the IDIs were re-
quired to have had a recent (past 4 weeks) diagnosis of
depression or having depression documented in their pa-
tient’s clinical records/files or indicated as a reason for
lost to follow up or missed clinic visits, in order to for
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them to be able to provide more depth of information
on contracts that arose from FGDs that needed more in-
formation based personal experiences on both hope and
hopelessness and depression. The other inclusion criteria
as indicated in for the phase I above applied for phase II.
In addition participants of the phase II were the partici-
pants of the larger NAMWEZA study and they were in-
cluded if they were living within the catchment area of
Kinondoni district at the time of enrollment and plan-
ning to remain living in Kinondoni for a minimum of 2
years and had been on ART for at least 3 months.
Exclusion criteria
For both phase I and II, people who were less than 18
years of age, not HIV infected, not enrolled for care in
the selected CTCs, not on ART medication, and not be-
ing well enough to attend the study interviews and inter-
vention sessions were excluded. Participants who were
not living within the catchment area of the former
Kinondoni district and those not planning to remain in
Kinondoni district after enrollment were excluded from
the phase II.
Primary outcomes
The primary outcomes included: developed initial draft
of local measures of hope, initial psychometric proper-
ties of the local hope measures and validated local hope
measures among PLH in Tanzania.
Phase 1: local hope items identification, content validity
and piloting
Identification of potential questions and domains of the
local hope scale
We combined both deductive and inductive approaches
to identify potential items to be included in local hope
scale. An extensive literature review to understand exist-
ing knowledge about the concept of hope and its do-
mains [1, 2, 4, 64–66] followed by an inductive approach
of generating items that could measure hope from the
emerging themes of the narrative data from participating
PLH. The items were then grouped into identified initial
domains of hope. The qualitative narrative data were
based on findings from a previously published study
among 78 PLH participating in 10 focus group discus-
sions (FGDs) and 8 in-depth interviews (IDIs). The par-
ticipants were selected based on the eligibility criteria
listed above. Purposive sampling was used to select the
FGD and IDI participants and in addition, snow ball ap-
proach was used in CTCs which we could not easily get
the IDI participants. The data for the FGDs and IDIs
was collected from February to June 2012. More details
are available in our previously published study [49]. The
data for phase I pilot survey were collected from June
2012 to early August 2012. The data were reviewed by
the study team members (local nurses, social workers
and physicians) to individually identify items describing
hope. Joint discussions were held and consensus reached
on 40 items that could be defined as having attributions
of hope (see A2 and A4 of Additional file 1). These
items included those that did and did not perfectly map
on the hope domains previously identified from the lit-
erature review, including those that were locally derived.
The team also placed narrative data emergent items into
three theoretical domains: depicting collaborative/influ-
ence of other people (12 items); affective /spiritual posi-
tive emotions such as feeling uplifted, comforted, being
secure and at peace (13 items); and a cognitive dimen-
sion including optimism and positive future anticipa-
tions/coping (15 items) (See A3 of Additional file 1).
Content validity of the identified hope scale items
The list of 40 items were reviewed further by a target
group of PLH and a multidisciplinary panel of experts
including one psychiatrist, one mental health researcher,
three social scientists, two public health and HIV health
care specialists, 1 postgraduate student in the mental
health department. The panel scrutinized the items and
the domains for correct definitions, relevance, ambiguity,
and what hope meant to the informants. This resulted
into modifying and expanding to include more specific
domains into 6 domains including; positive emotions,
current and future fear of living with HIV, satisfaction
with HIV care/positive attitude towards HIV and care,
planning and positive future expectations (A 3 of Add-
itional file 1) The target population review was done by
a group of ten PLH who provided feedback on each
item, including its clarity and appropriateness as an at-
tribute of hope from their perspective (if the items really
reflected what PLH perceived as hope). Based on this we
edited the grammar and word choice in the Swahili lan-
guage rephrased some of the items.
The list was then sent to two experts psychiatrists rec-
ognized by having published work on depression, stress
disorders or hope, having a reputation as skilled clini-
cians working within the Tanzanian mental health and
HIV areas who were part the NAMWEZA study. The ex-
perts, HIV clinic staff and graduate students were asked
to review and rate each of the local idioms on the list in
a scale of 1 to 5 on the extent to which they thought the
item characterized local experiences of hope, as 1 = not
at all characteristic, 2 = somewhat characteristic, 3 = no
sure if characteristic or not characteristic (neutral), 4 =
characteristic and 5 = very characteristic.
This was followed by a pile sorting and rating by the
10 PLH who had provided inputs earlier whereby a pile
of cards with different idioms of hope were presented to
them by having the study RA read the cards aloud to
allow more clarity to the participants and to help those
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that were illiterate to understand. Each participant, pri-
vately placed cards in any of the boxes each labeled with
1 of the 6 domains of hope identified and also wrote and
added any description of hope they felt was different
from what was in the cards. The PLH also rated the
items placed in each box using a visual and verbal analog
Likert scales that allowed the participants to rate the
items in each box from 1 to 5; 1 = not at all characteris-
tic, 2 = somewhat characteristic, 3 = sure if characteristic
or not characteristic, 4 = characteristic, 5 = very charac-
teristic, through placing a circle on a visual and verbal
analog scale the extent to which they felt that the idiom
fitted the selected domain on each of the cards and for
each of the domains to allow for possible overlap in ex-
pressions used for the concepts of interest. The ratings
were analyzed systematically. This process resulted into
a removal of 7 items (Fig. 1) that were felt to be ambigu-
ous or complex or not attributed hope and generation of
the final list of the most frequent items on the PLH’s
lists were assessed with those generated by experts and
health care providers of items for measuring hope that
was then piloted among 318 PLH at 8 large CTCs in
Dar es Salaam.
Pilot testing and initial psychometric properties
The remaining 33 items were phrased as opinion
statements with a four-option Likert scale response
format (definitely false = 1, somewhat false = 2, some-
what true = 3, and definitely true = 4), and piloted
among 318 PLH.
Sampling and data collection for pilot testing
Our sample size for the pilot survey was based on evi-
dence and recommended minimum sample for factor
analysis which is 2–20 times the number of variables
[67]. We had 33 variables and we iteratively chose our
sample fit by looking at the Kaiser-Meyer-Olkin meas-
ure of sampling adequacy which was 0.83 thus above
the commonly recommended value of 0.6 for factor
analysis and Bartlett’s test of sphericity, which was sig-
nificant for the hope scale items (χ2 (253) = 24,960.00,
p < 0.0001) when our sample was 300. To allow for
potential non-response, and missing data we randomly
selected and enrolled 318 PLH from 10 large HIV care
and treatment clinics who agreed to participate and
completed the pilot questionnaire with a response rate
of 100%.
Pilot testing procedures
The 33 hope items derived from the qualitative data
were piloted among 318 pilot survey participants PLH.
The aim of the pilot was to get a first glimpse of the
initial responses to the local hope scale items, to ex-
plore items that may have been difficult to understand
Fig. 1 Flow diagram summarizing the procedures used to develop the local hope scale
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and make rephrasing or removal decisions, as well as
the initial psychometric properties of the scale before
phase II of validating the scale in a baseline and
follow-up (occurring 24 months after baseline) surveys
nested within the NAMWEZA effects evaluation
survey [47] started. This entailed examining item re-
sponse rates and item-item bivariate correlations to
identify extreme responses and unanswered items.
Items that had 90% or higher non-response rates were
removed, with the assumption that participants found
them unclear, or redundant. Items with Spearman’s bi-
variate correlation coefficient(r) < 0.3 or > 0.9 were
also removed. This resulted in 20 items for inclusion
in the next phase of the analysis.
Hope pilot study data were collected using a paper-
based questionnaire administered on a face-to-face
interview with eligible PLH done by trained social sci-
entists. The trained study RAs contacted every third
person coming for their routine HIV clinic visit in
the selected 8 CTCs for eligibility prior to an in-
formed consenting process. This was done in order to
allow time for screening and reasonable spacing of
participants screened to avoid selecting groups of
people who come together who might be peers and
may be share similar characteristics and leave out
other eligible participants who could be different from
the groups. The process continued until the targeted
number of participants to be enrolled was reached.
Exploratory factor analysis (EFA) and scale reduction
Exploratory Factor Analysis (EFA) was conducted on the
20-items to identify the optimal number of factors or
hope constructs that could be extracted by examining
eigenvalues or the variance in response that they ex-
plained. Factors loading with eigenvalues equal to or
greater than one were considered potential to retain. In
each specific factor extracted only individual items load-
ing at 0.3 or more were retained. Finally, scale reliability
analyses were conducted retaining only those items that
improved internal consistency, as assessed using Cron-
bach’s alpha, without altering the meaning of the ex-
tracted factors. In addition, we checked at each step,
item-item bivariate correlations to ensure items that had
very small (r < 0.3) or very high correlation coefficients
(r > 0.9) were removed. (Fig. 1). These analyses resulted
in retaining 10 items of the hope scale which were then
subjected to confirmatory factor analyses (CFA) and
scale reliability evaluation.
Additionally, EFA revealed the potential number of
hope dimensions that our data would most likely present
by looking at the plot of relative values of eigenvalues
for each hope factor (also known as a scree plot) that fell
above the plot’s elbow point (a point where the plot be-
comes horizontal). This captures factors with items that
explain substantial levels of variance and is an indication
of factors that contribute to the hope scale’s structure. A
parallel analysis (Fig. 2) further confirmed the potential
Fig. 2 Comparison of study Eigenvalues with simulated Eigenvalues Depicting 3 Factor Solutions during Pilot
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number of factors for our data. This is through examin-
ation of computer simulations of multiple random data-
sets which generated simulated eigenvalues that we
compared to the actual eigenvalues resulting from our
data. The simulated eigenvalues indicate the amount of
random variance in the data that would be expected by
chance, therefore actual eigenvalues that exceed simu-
lated eigenvalues were considered candidates for reten-
tion in the scale’s factor structure. In these analyses,
1000 randomly selected datasets were used to generate
simulated eigenvalues [68]. Finally, EFA revealed the in-
ternal consistency of the hope scale as measured at dif-
ferent points while reducing the number of items until
we reached our final number of items, with the most
reasonable meaning and internal consistency that was
within an acceptable range (Fig. 2).
Phase II: Hope scale evaluation
The purpose of phase II analyses was to explore and
confirm the post-pilot tested hope scale’s psychomet-
ric properties and its structure. Baseline data were
collected from August –end of October 2012 while
follow up data were completed in January 2014. In
addition follow-up data for assessing hope were col-
lected from March to June 2014.
Local hope measures were collected using a paper-
based questionnaire while an Audio Computer-Assisted
Self-Interview (ACASI) software captured demographic
characteristics and other variables of interest for the lar-
ger NAMWEZA study which were extracted and linked
to the local hope measures using unique participants ID.
Descriptive characteristics confirmatory factor analyses
were conducted using SPSS statistical software, versions
20 and 23 [69]. The confirmatory factor analysis was
done using SPSS 23 with AMOS software plugins.
Confirmatory factor analysis (CFA)
This was conducted in order to test for dimensionality
of the hope local measures. We hypothesized that the
factor structure extracted during baseline survey and at
24 months of follow-up time would be approximately
the same [70] and conducted the test of invariance using
CFA model fit using the AMOS program [71] to run the
analysis and used 4 indices to confirm the model fit: in-
cluding chi-square test of exact fit; Root Mean Square
Error of Approximation (RMSEA ≤0.08); Tucker-Lewis
Index (TLI was 0.978); and the Comparative Fit Index
(CFI ≥ 0.969).
Assessment of hope scale reliability
We defined reliability as a degree of consistency exhib-
ited when the hope measurement is repeated under
identical conditions. Internal consistency was tested
using Cronbach’s Alpha and value of a larger than 0.75
indicates satisfactory internal consistency for the main
scale and subscales. Test-retest reliability was assessed
using two subsequent time points at baseline and 24
months of follow-up [70]. The test-retest reliability was
used to assess the degree to which participants sum
scores were persistent across time. Intraclass correlation
coefficient was calculated to estimate test-retest reliabil-
ity with correlation efficiency higher than 0.5 considered
as good reliability.
Construct validity
Convergent validity was performed by examining the
associations between the hope scale scores and similar
constructs using Pearson correlation coefficient.
Stronger correlation coefficients indicating support for
convergent validity. In addition, the correlations be-
tween mean hope and that of constructs from the lit-
erature, including knowledge, social support, self-
esteem, adherence to clinic visits, clinical parameters
including weight and CD4 + T cells that were expected
to be positively associated with hope were used as
additional tests of convergent validity. We created a
mean hope score from the 10 final items ranging from
‘1’ for complete disagreement to ‘4’ for complete
agreement with items. This was followed by determin-
ing Pearson’s correlation coefficients between the
hope scale mean and selected constructs that we ex-
pected to be negatively or positively associated with
hope. These included: general knowledge about HIV
ART medication, depression; stigma; social support;
self-esteem; and adherence to medication and clinic
visits. For the convergent validity, we hypothesized a
positive relationship between mean hope scores and
higher general HIV knowledge, knowledge about ART
scores; and similarly, to with other positive constructs
including high self-esteem and social support, and
good adherence to ART and clinic attendance on
scheduled visits. In addition, we hypothesized that
positive clinical outcomes will be positively correlated
with hope scores with the strength of the association
providing support for convergent validity.
Discriminant validity
Was assessed by examining the relationship between
the hope scale mean scores and distinct constructs
from the literature that are negatively related to hope.
We hypothesized that depression assessed using the
PHQ-9, stigma, and the locally derived msongo (a
local tool for measuring stress) and sonona (a local
tool for measuring depression would be negatively
correlated with the local hope measures. Small and or
negative correlation coefficient was used to support
discriminant validity.
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Results
Description of the study sample
A total of 722 PLH participated: 78 from our previous
qualitative study (49); 318 PLH in the pilot survey; and
326 PLH participated in the baseline and 24months’
follow-up surveys. Descriptive characteristics for the
study sample at baseline are shown in Table 1. The par-
ticipants’ age ranged from 18 to 75 years with a mean of
39.3 years (SD = 10.1) and about 59% were women. The
mean number of years spent on primary and secondary
levels of formal education was 6.8 years, (SD = 0.75), ran-
ging from 2 to 8, and 4.4 years (SD = 1.8) ranging from 2
to 8, respectively. The mean years at college and degree
education was 3 years (SD = 1.2), from 1 to 4, and 3.08
years (SD = 2.0) ranging from 1 to 6 respectively. Partici-
pants had low general HIV knowledge (mean score was
3.4; SD = 3.9 which was below half of the expected 8
points. and had a mean score for depression falling
below the cut-off score of 9 for clinically significant de-
pression (mean 8.0; SD = 5.6; range 0–27. Mean score
for internalized HIV related stigma was above average at
3.6 (SD = 0.95; range 1–5). Participants attended at least
1 clinic visit per month with an annual average of 12.4
(SD = 4.6; range 1–38) clinic visits, had moderate scores
of ART adherence; 1.7 scores, (SD = 0.3) ranging from 1
to 3, had moderate hemoglobin levels with a mean of
(11.2 mmol/L) SD = 2, range from 5 to 16mmol/L, and
low CD4+ T cells, average 338 cells /mm3, (SD = 188.6),
ranging from 0 to 1212 cells/mm3. The mean weight for
the participants was 59.9 kg, (SD = 10.8), ranging from
30 kg–105 kg (Table 1).
Hope scale development and validation
Item selection and reduction
The detailed descriptions from PLH of the meaning and
how they experienced hope, as well as our theoretical con-
ceptual framework on which we based to develop our
scale is available in our previously published paper [49].
Of the 33 hope scale question items derived from
FGDs and IDIs piloted among 318 PLH one item (item
number 30) was removed because it had a low response
rate where almost 95% of the PLH chose not respond to
it, most likely because the item was unclear and partici-
pants might have not understood it well. The local hope
scale remained with 32 items of which 22 items which
had mean scores of 3 and above ranging from 3.0 (SD =
0.96) to 3.53 (SD = 0.78). Ten items had mean scores
ranging from 2.0 (SD = 1.90) to 2.97 (SD = 0.93) while
only 1 item had a mean score slightly less than two; 1.99
(0.17) (See A5 and 6 of Additional file 1). Over 50% of
participants rated 31 items towards hopeful (somewhat
true) or very hopeful (definitely true), while 50% of par-
ticipants responded definitely false to 1 item (A5 of Add-
itional file 1). Eight other items had very low correlation
coefficients (r < 0.3) while 4 items had very high correl-
ation coefficients (r > 0.9) and were also removed leaving
the local hope scale with 20 items (Fig. 1).
Exploratory factor analyses (EFA) and hope scale reliability
The initial 20 hope scale items when subjected to EFA
during the pilot, the derived scree plot elbow-point and
parallel analysis suggested the extraction of three factors
contributing to most of the variance in factor loadings,
indicating a 3-factor solution depicting positive emotions
(affect), planning/plans and positive future expectations.
The 20-item hope scale items had a very good internal
consistency with Cronbach’s alpha 0.81. Through an
Table 1 Descriptive Characteristics of the Study Participants at
Baseline (N = 326)
Characteristic Sample/n (%) Mean/score (SD) Range
Age in years 39.0 (10.1) 18–75
Sex: Women 192 (59)
Employment status
Employed/self-employed/
housewife/student
283 (87)
Not employed 43 (13)
Years in School
Primary School 6.8 (0.8) 2–8
Secondary School 4.4 (1.8) 2–8
Non-degree/Collage 3.0 (1.2) 1–4
Degree/University 3.1 (2.0) 1–6
General HIV knowledge 3.6 (3.9) 1–8
Knowledge about ART 2.8 (0.6) 1–4
Hope 2.6 (0.5) 1–4
Psychosocial health:
aDepression scores 8.0 (5.6) 0–27
Self-esteem 3.1 (0.6) 1–4
Stigma 3.6 (1.0) 1–5
bPerceived social support 2.3 (0.5) 1–3
Local scale of stress
scores (msongo)
18.4 (4.3) 0–20
Local scale of depression
scores (sonona)
38.1 (6.0) 0–64
Health seeking behavioral
Adherence to medication 1.7 (0.7) 1–3
Clinic visits 12.4 (4.6) 1–38
Clinical outcomes
Hemoglobin(g/dl) 11.2 (2.0) 5–16
CD4+ T cell (cells/mm3) 338.6 (188.6) 0–1212
Weight (kg) 59.9 (10.8) 30–105
aDepression scores were measured by PHQ9 tool >/=9 is depression. Scores < 9
no mild or no depression
bPerceived social support was measured by (name of the scale) scale, whereby
1 = perceived the highest support, 4 perceived no support
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iterative approach of excluding items that loaded < 0.3
on a single factor, while maintaining an internal
consistency of Cronbach’s alpha of 0.750 and above,
eight more items that loaded less than 0.3 in individual
factors were removed remaining with a 12-item hope
scale with an internal consistency of Cronbach’s alpha
0.87. After more reflection and discussions on how
meaningful the items were in each dimension, two items
were removed from the hope scale without compromis-
ing the internal consistency (Cronbach’s alpha, 0.89),
retaining 10 items in the hope scale. The three dimen-
sions of this reduced scale explained 69% of the total
variance and these dimensions included positive affect,
cognition of effectiveness of HIV care, and future opti-
mism, with internal consistencies of 0.84, 0.78 and 0.79,
respectively (Table 2).
The evaluation results indicated that the intraclass
correlation coefficient between baseline and 24 months
of follow-up was high and within the acceptable ranges
(r = 0.797) and thus positive for test-retest reliability.
Local hope scale dimensionality
A total of 10 items were subjected to CFA. All 4 indices
for CFA model fit were supportive of a three-factor
structure; at baseline, the Root Mean Square Error of
Approximation (RMSEA) was 0.045, and the Chi-Square
test was insignificant (p = 0.13) as recommended, the
Tucker-Lewis Index (TLI) was 0.977 and the Compara-
tive Fit Index (CFI) was 0.984. When the baseline survey
data were compared with the follow-up survey data the
test of invariance for the hope scale was confirmed, with
most of the parameters indicating model fit; the RMSEA
of 0.032 at follow-up was less than the recommended
upper limits of 0.08. However, the Tucker-Lewis Index
(TLI) was 0.971 which is above the recommended lower
limits of 0.96, and the Comparative Fit Index (CFI) was
0.975 which is higher than the recommended lower limit
of 0.969. In both models, the regression weights indicated
that all indicator variables loaded as significant factors and
all group correlations were more than 0.5 which is the
minimum recommended thus confirming a model fit for
the three hope dimensions for the 10-item scale.
Validity of the 10-item hope scale-construct validity
At baseline, the mean of the 10 hope scale items was
2.6 (SD = 0.52, range 1.0–4.0, IQR = 0.46) at baseline.
Pearson correlations coefficient between hope and our
selected constructs were supportive of a priori hypotheses,
although not all were significant. Higher scores of general
knowledge about HIV had significant and positive correl-
ation with the local hope scale at baseline (r = 0.281 p <
0.001) and at follow-up (r = 0.422, p < 0.001), similarly
higher scores of knowledge about ART were significantly
and positively correlated with hope although the Pearson
coefficient was quite small at baseline (r = 0.161, p = 0.003)
but high at follow-up (r = 0.544, p < 0.001). Likewise Self-
esteem and social support, adherence to ART and attend-
ance to scheduled clinic visits were also positively corre-
lated with hope at baseline (r = 0.178, p < 0.001), (r = 0.209,
p < 0.001), (r = 0.111, p = 0.001), and (r = 0.131, p = 0.0018)
respectively. At 24months of follow-up the same variables
much high strength of positive correlations with hope
Table 2 Local hope scale items loading and dimensions, at baseline and at 24 months follow up
Hope Scale Item Baseline (N = 326) Follow up (N = 326)
Dimension 1 = Affective /positive emotions
I am Happy 0.740 0.802
I have peace 0.692 0.813
I feel I have new strength to move on 0.680 0.759
My heart is cheerful 0.649 0.763
Dimension 2 = Cognitive positive results of HIV /ART care
I am satisfied with my progress since I started ARVs 0.749 0.889
I believe to follow the advice from my counselor, brings me good results for my health 0.729 0.829
All my needs for HIV care that I need for my HIV condition are all met 0.555 0.796
Dimension 3 = planning and future optimism
I can reach/meet my goals 0.712 0.833
I believe in my plans 0.700 0.771
I can live a long life and continue with my routine activities 0.602 0.846
Overall internal consistency of the local hope scale 0.869 0.958
Internal consistency Cronbach’s Alpha for subscales 0.843 0.778 0.789 0.93 0.90 0.92
Total Variance explained 45% 13% 10% 64% 20% 10%
Total variance explained 69% 93%
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except for social support and clinic visits which remained
small but significant; Self-esteem (r = 0.449 p < 0.001),
social support (r = 0.101 p = 0.003), attendance to
scheduled clinic visits(r = 0.176 p = 0.04) and adherence
to ART(r = 0.338 p < 0.001). The clinical outcome vari-
ables were also positively correlated with hope, and
while this direction was confirmed the correlations were
not significant at baseline; CD4 +T cell counts (r = 0.035,
p = 0.532), hemoglobin (r = 0.061, P = 0.270) and Weight (r
= 0.027, p = 0.626) and at 24months follow-up the strength
of the positive correlations increased but none of them
were significantly correlated with hope; CD4 +T cell counts
(r = 0.224, p = 0.0.09), hemoglobin (r = 0.118, P = 0.16) and
Weight (r = 0.244, p = 0.07).
In terms of divergent validity, all the hypothesized var-
iables correlated negatively with the local hope scale at
both baseline and follow-up. Higher scores of depression
measured using PHQ-9 tool and stigma had significant
negative correlations with hope; (r = − 0.190, p < 0.001)
and (r = − 0.276, p = 0.001) respectively at baseline and
during follow-up same direction of correlation was ob-
served but with much stronger correlations; depression
(r = 0.556 p < 0.001) and stigma(r = 0.348 p < 0.01). In
addition, the locally developed scales for depression
(sonona) and stress (msongo) from populations of PLH
had moderate to strong negative correlations with the
local hope scale (r = − 0.411, p < 0.001) and (r = 0.398,
p = 0.004) respectively at baseline and at follow-up the
strength of negative correlation of sonona and with the
local hope scale was much stronger (r = 0.566) while that
of msongo decreased slightly (r = 0.310) but they were both
significantly negatively correlated with hope (p < 0.001)
(Table 3) and (See A1 of Additional file 1).
Discussion
We have developed and validated a measure of hope
which to our knowledge is the first to be developed for
use specifically among adult PLH accessing care and
treatment, in a high HIV prevalence urban setting of a
low-income country. The three dimensions of hope in
our scale are not completely different from previously
developed hope scales. A more recently developed local
hope scale among PLH in similar settings of South Af-
rica, which focused on HIV infected young women aged
13–20 years [45], showed one dimension reflecting fu-
ture expectations and meeting goals. This dimension is
similar to the third dimension of our hope scale; positive
future expectations and meeting goals. Moreover, our
question items under this dimension were similar; Ex-
ample our item HS23 “I can reach/meet my goals” was
similar to the question item PM7 “It is easy for me to
reach my goals” [45] in the South African local hope
scale. Setting goals and working toward them effectively
is an important aspect of hope. It is consistent with the
most recent definition of hope which includes not just
positive future expectations (optimism) but actually
playing a role to establish the expected positive future
[4, 72] by making and meeting goals. This dimension is
also similar to that of the Snyder Hope Scale which has
“goal-directed energy” as one of its dimensions of hope.
Table 3 Construct Validity Assessment: Pearson’s Correlation of Selected Variables with Mean Hope Scores (N = 326)
Validation measures Baseline 24 Months follow up
Correlation with mean hope p-value Correlation with mean hope p-value
Socio-demographic
General HIV knowledge 0.281 < 0.001 0.422 < 0.001
Knowledge of ART medication 0.161 0.003 0.544 < 0.001
Mental health
Depression PHQ9 scores(−) −0.299 < 0.001 − 0.348 0.002
Self- esteem (+) 0.178 < 0.001 0.490 < 0.001
Stigma(s) (−) −0.276 0.001 −0.446 < 0.001
Social support(+) 0.209 < 0.001 0.101 0.023
Local scale of stress (msongo) −0.398 0.004 −0.310 < 0.001
Local scale of depression (sonona) − 0.411 < 0.001 − 0.566 < 0.001
Behavioral risk
Adherence to ART (+) 0.110 0.005 0.338 0.006
Attendance to clinic visits (+) 0. 131 0.018 0.176 0.040
Clinical outcomes
CD4 (+) 0.035 0.532 0.224 0.092
Weight 0.027 0.626 0.244 0.070
Hemoglobin (BHG) 0.061 0.270 0.188 0.160
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The Herth Hope Scale however includes an item that
explores the presence of goals [1, 64], though in our
scale the three items on meeting goals, plans and posi-
tive future expectations loaded together as one dimen-
sion. This could mean that our current study
participants associated goals and the pathway which is
following plans in order meet goals for the expected
positive future, similar to the above-mentioned argu-
ment about hope being optimistic about future and play-
ing a role to get to the future.
The other dimension that we found in our local hope
scale of positive emotions /affect. This is not reflected in
many of the existing hope scales except the Herth hope
scale where a dimension of positive readiness includes
an item about a feeling of deep inner strength [64].
The third dimension of cognition about positive results
of care as a dimension of hope is not reflected in any of
the existing hope scales in similar settings and in devel-
oped countries. This could be due to the fact that our
study population was receiving ART and had expressed
positive beliefs on the effectiveness of ART as part of their
hope attributions. Since ART does suppress HIV viral load
to undetectable plasma levels allowing restoration of the
immune system, most PLH with good adherence to ART
would likely have no symptoms [73–75], making this
population different from that of patients with other
chronic or terminal illnesses that have been involved in
the development of hope scales including persons with
cancer, diabetes etc. Such patients may have disabling
consequences of illness despite effective treatment/therapy
compared to ART. It could also be a reflection of partici-
pant characteristics, as the majority (87%) of our partici-
pants were employed, self-employed, housewives and
students who might be expecting to recover quickly from
their symptoms in order to continue with their duties. A
study that explored hope among patients with lung cancer
reported that hope was inversely related to cancer symp-
tom severity [76]. Persisting symptoms after starting ART
may not be expected by PLH, explaining why this dimen-
sion may be important in this population. This new di-
mension could facilitate identification of clinical aspects of
HIV care that if improved may prevent hopelessness and
its negative impacts on mental health, adherence to ART
and quality of life in PLH [28, 29]. It is also likely that this
new dimension is reflecting the Tanzanian cultural values
that relate with having no hope mzigo (which means be-
coming a burden or useless) to the relatives and family. As
adults PLH with families, with some being widows and
widowers, they value their ability to support their families.
Likewise the PLH who are young strive to reach the cul-
turally expected milestones of getting education, marriage
within expected time, building a house and having chil-
dren. Such achievements in Tanzanian culture brings a
sense of honor, respect, dignity and motivation. Failing to
this which can come as a result of HIV related frequent ill-
nesses or prolonged poor health causes distress, frustra-
tion and hopelessness [77]. The fight to recover from
symptoms and go back to work or proceed with school as
normal could be a fight for survival need for the PLH to
maintain their cultural values in this setting [12]. This is
also similar to a study conducted in Afghanistan that
found maintaining personal and social dignity based on
cultural values was a key to hope [7].
However there are social structural issues that can also
affect hope study of hope. This study focused on the hope
scale development and psychometric properties however,
social structural issues of hope including access to know-
ledge about HIV and available treatment, counseling, so-
cial support groups, support from families especially
spouses, were discussed in our previous study before this
[49]. Another study that explored the perceptions of hope
among youths in Tanzania revealed that the street youths
that attributed their hope to social structures including ex-
ternal attachments to supporting adults, shelter, money,
ability to access schooling work and future. The youths in
homes however attributed their hope to better school per-
formances to enable them to take care of their parents
and care takes in future [78]. This is similar to studies
conducted in South African which found hope levels were
different among marginalized groups and not different
among age groups [79, 80].
These findings are similar to previous literature and
supports the argument that the dimensions of hope
include cultural context in which a person’s culture pro-
jects as hope or hopelessness and that hope is not a
universal experience to all groups or only cognitive
process of goal attainments, but contexts in which hope
is attained including culture is important [81].
The local hope scale was developed considering the
local cultural context, as attributions of hope were derived
from the narratives of PLH while taking into consideration
more globally understood dimensions of hope. The items
in the local hope scale are internally consistent both
within the overall scale and its three subscales (dimen-
sions). Our narrative data from qualitative research availed
many (40 items) potential items that informed the devel-
opment of the local hope scale, with the three extracted
dimensions having resonance in this population of PLH
being collaborative influences from others, positive affect,
spirituality and positive illness /treatment-related cogni-
tion, plans, goals and positive future expectations. Our It-
erative factor reduction approach resulted in a 3-factor
structure including affective/positive emotions, cognition
of effective care and future optimism which were similar
to what we saw in the qualitative data [45, 82]..
Our study found preliminary support of good con-
struct validity of the hope scale in the directions and
magnitude of correlations between hope and variables
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that we hypothesized to have correlation with hope. The
strength of the correlation was moderate at baseline
except for the clinical outcome variables of CD4, HBG
and weight and local measures of depression and stress
which were small but increased during follow-up which
is attributed to the effect of NAMWEZA intervention.
We also found convergent validity of the scale indicated
by significant correlations of hope scale with depression,
HIV knowledge, self-esteem, and social support, adher-
ence to medications and clinic visits and clinical out-
comes parameters.
This is similar to previous reports from multiple stud-
ies, that show hope was positively associated with know-
ledge [45], self-esteem [83, 84], social support [45], and
adherence to medications and clinic visits [14–16]. Our
study indicated that hope was not significantly correlated
with clinical outcomes such as the CD4 positive T cell
count, weight and Hemoglobin (HBG) levels. We found
no previous literature linking the direct effects of hope
on clinical outcomes. Similar to what we found, most
literature reports that hope mediates [24] other factors
including resilience, coping, compliance with care, self-
esteem and quality of life which might impact clinical
outcomes positively. The low rates of hopefulness found
in this study population are perhaps characteristic of
PLH accessing care as they were derived at baseline
prior to the NAMWEZA psychosocial intervention that
could likely improve hope.
The negative direction of correlation between hope
and depression which indicated divergent validity was
similar to what has been reported from previous studies
[66]. A meta-analysis conducted in 2008 revealed that
most studies reported hope was negatively correlated
with the mental health disorders of depression and anx-
iety but positively correlated with subjective health, qual-
ity of life and self-esteem and [85]. A more recent study
reported that hope was negatively correlated in persons
with schizophrenia, with levels of internalized stigma,
but positively correlated with resistance to stigma [86].
The hope scale was also negatively correlated with lo-
cally developed depression and stress scales at strengths
that were mild to moderate when compared to the
PHQ-9 depression scores, most likely because the local
scales were developed in similar populations of PLH and
in local culture thus the items may be clearer and have
greater resonance. The almost similar strength of the
correlations between the hope scale and our locally de-
veloped measures of stress and depression could also
imply that these local distress terms used to describe
depression and stress could have similar meanings as
indicated in our previous study [49].
The hope measure could support the efforts to im-
prove the wellbeing of PLH in high prevalent settings of
Tanzania. Whereas studies have reported that preventing
and addressing mental health concerns including anxiety
and depression among PLH has the potential to improve
HIV treatment outcomes [87], recent reports in Tanzania
indicate both adolescents and adults living with HIV/AIDS,
had increased rates of depression by four times in adoles-
cents with compared to those without HIV [51, 88, 89]. In
addition the integration of mental health care within the
primary and HIV care services remains limited [43, 90–92]
in part due to limited number of trained health care pro-
viders and even fewer with mental health care competen-
cies as well as stigmatization of mental health conditions in
the community [43, 90, 92, 93]. A meta-analysis of studies
that report the effects of hope therapy indicated that while
effects were small for management of particularly severe
depression, hope theories can guide management of
depression among patients with chronic illnesses [94].
Other studies supporting this observation show that hope
therapy and other hope related interventions are effective
in addressing depression among patients with chronic
physical illnesses [21–23]. In this context, this simple
measure for determining hope may be a first step to identi-
fying clients for depression prevention interventions so as
to improve HIV clinical outcomes the overall mental well-
being and quality of life of PLH. Moreover interventions
that improve access to ART comprehensive services, re-
peated counseling, managing side effects of ART [49, 77],
and active monitoring of HIV viral load to ensure PLH are
virally suppressed [53, 95–97] and thus healthy enough to
able to return to their social and cultural priorities could
increase hope and its other benefits among PLH.
Limitations
The NAMWEZA study sample included only PLH en-
rolled in care and taking ART. This excluded PLH who
were not yet enrolled in care and not taking ART. PLH
in Tanzania who are not in care are more likely to have
limited information about HIV, due to lack of frequent
HIV care counseling offered in CTCs. They are also
more likely to have deteriorating health due to the fact
that they are not on ART thus their serum HIV viral
load could to be high allowing them to get HIV related
opportunistic infections. Excluding this group from this
study potentially limits generalizability of the study to
the PLH who are not yet in care or not taking ART.
Although the evaluation study happened in1 large hos-
pital of Sinza which could limit generalizability, the tool
was developed and piloted in 8 large CTCs across all dis-
tricts of Dar es Salaam. The study was based on an
urban congested setting with easier access to HIV care
services in all districts. Rural settings, however, might
have fewer HIV care clinics located a longer distance
from homes, resulting in more difficulty for PLH to ac-
cess HIV care services, which can impact the level of
hope. Also our hope scale was not tested among people
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who were not HIV infected and we did not explore how
the scale performed in different social groups like gen-
der. These will be explored in future studies.
In addition our scale is much more inclined to issues
of HIV/AIDS related symptoms and the ability to access
clinical care, which can affect hope. This is because the
scale is based on the perceptions of our population of
PLH on hope in Tanzanian settings and the conceptual
framework available in our previous paper which also in-
clude some social structural issues but their question
items were removed from the scale because of poor
loadings [49]. Being health was culturally very important
because it allowed PLH to achieve their individual plans
and what the community expected of them. However fu-
ture studies exploring hope scales among PLH should
explore other social structural issues.
Conclusion
In summary, our study identified a locally derived 10-
item latent measure of hope among adult men and
women PLH in an area with a high prevalence of HIV.
The extracted dimensions of the scale constructs were
more than the common dimensions of goal oriented
thinking, pathways and motivation previously reported
in globally used measures of hope, but included positive
cognition about HIV care received and its effectiveness
mainly linked to becoming normal in order to support
families. Evaluation of the local hope scale indicates it
has demonstrated high construct validity and good reli-
ability. This is a simple measure could support early
identification and prevention of hopelessness and mild
to moderate mental health conditions among PLH in
Tanzania and similar settings.
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